Da Huang - Sheng
Granule SingleHerbs

Da Huang - Sheng

生大黄

Radix et Rhizoma Rhei

Login to see price

Regular, Wholesale & Super VIP pricing available

Sign In
In Stock
SKU: D0570
80139729
Concentration Ratio: 6:1

Description

RHEI RADIX ET RHIZOMA (大黄, Dahuang) Rhubarb The dried root and rhizome of Rheum palmatum L., Rheum tanguticum Maxim. ex Balf., or Rheum officinale Baill. (Fam. Polygonaceae). The drug is collected in late autumn when the stems and leaves have withered, or in the following spring before sprouting. Rootlets and the outer bark are removed, the drug is cut into pieces or segments, either strung together for drying or dried directly. Description In subcylindrical, conical, ovoid, or irregular pieces, 3–17 cm long and 3–10 cm in diameter. Externally yellowish-brown to reddish-brown after peeling, sometimes with whitish reticulations and scattered star spots (abnormal vascular bundles) visible; occasionally bearing brownish-black patches of cork; mostly with a hole through which a string has passed; and with coarse longitudinal wrinkles. Texture compact, sometimes rather loose and soft in the centre. Fracture pale reddish-brown or yellowish-brown, granular. Pith of the rhizome broad, with star spots arranged in a ring or irregularly scattered. Wood of the root well developed, radially striated; cambium ring distinct; star spots absent. Odour delicately aromatic; taste bitter and slightly astringent, becoming sticky and gritty upon chewing. Identification (1) Microscopic Identification Transverse section Most of the cork and phelloderm of the root removed. In the phloem, sieve tube groups distinct and parenchyma well developed. Cambium forming a ring. Xylem rays relatively dense, 2–4 cells wide, containing brown masses. Vessels unlignified, usually solitary or in small groups, sparsely distributed. Parenchymatous cells containing clusters of calcium oxalate and abundant starch granules. Pith of the rhizome broad, usually with mucilage cavities containing reddish-brown masses. Abnormal vascular bundles scattered. Cambium forming a ring, with xylem outside and phloem inside the cambium. Rays stellately radiating. Powder Yellowish-brown. Clusters of calcium oxalate 20–160 μm in diameter, occasionally up to 190 μm. Bordered-pitted, reticulate, spiral, and annular vessels unlignified. Starch granules abundant; simple granules subspherical or polygonal, 3–45 μm in diameter, with stellate hilum; compound granules composed of 2–8 components. (2) Sublime a small quantity of the powder. Rhombic needle crystals or feathery crystals are visible. (3) Macerate 0.1 g of the powder with 20 ml of methanol for 1 hour and filter. Evaporate 5 ml of the filtrate to dryness. Dissolve the residue in 10 ml of water, add 1 ml of hydrochloric acid, heat under reflux on a water bath for 30 minutes, and cool immediately. Extract with two 20 ml portions of ether. Combine the ether extracts, evaporate to dryness, and dissolve the residue in 1 ml of chloroform as the test solution. Prepare the reference drug solution in the same manner using Rhei Radix et Rhizoma Reference Drug. Dissolve rhein CRS in methanol to produce a solution containing 1 mg/ml as the reference solution. Carry out the method for thin-layer chromatography (0502), using silica gel H mixed with sodium carboxymethylcellulose as the coating substance and the upper layer of a mixture of petroleum ether (30–60°C), ethyl formate, and formic acid (15 : 5 : 1) as the mobile phase. Apply separately 4 μl of each of the above three solutions to the plate. After developing, remove the plate, dry in air, and examine under ultraviolet light at 365 nm. The five orange fluorescent spots in the chromatogram obtained with the test solution correspond in position and colour to those in the chromatogram obtained with the reference drug solution. The orange fluorescent spot in the chromatogram obtained with the test solution corresponds in position and colour to that in the chromatogram obtained with the reference solution. The spot becomes red on exposure to ammonia vapour. Rhaponticin To 0.1 g of the powder add 10 ml of methanol, ultrasonicate for 20 minutes, and filter. Dilute 1 ml of the filtrate to 10 ml with methanol as the test solution. Dissolve rhaponticin CRS in methanol to produce a solution containing 10 μg/ml as the reference solution (prepare freshly before use). Carry out the method for thin-layer chromatography (0502), using polyamide as the coating substance and a mixture of toluene, ethyl formate, acetone, methanol, and formic acid (30 : 5 : 5 : 20 : 0.1) as the mobile phase. Apply separately 5 μl of each solution to the plate. After developing, remove the plate, dry in air, and examine under ultraviolet light at 365 nm. The bright blue fluorescent spot in the chromatogram obtained with the test solution should not correspond in position and colour to the spot in the chromatogram obtained with the reference solution. Water Not more than 15.0% (0832, Method 2). Total Ash Not more than 10.0% (2302). Acid-insoluble Ash Not more than 2.0% (2302). Extractives Carry out the hot extraction method for the determination of ethanol-soluble extractives (2201), using 70% ethanol as the solvent; not less than 22.0%. Assay Carry out the method for high-performance liquid chromatography (0512). Chromatographic System and System Suitability Use octadecylsilane-bonded silica gel as the stationary phase and a mixture of methanol and water (15 : 85) as the mobile phase. The detection wavelength is 275 nm. The number of theoretical plates of the column is not less than 2000, calculated with reference to the peak of salidroside. Reference Solution Dissolve salidroside CRS, accurately weighed, in methanol to produce a solution containing 0.5 mg/ml. Test Solution Accurately weigh 0.5 g of the powder (through No. 3 sieve) into a stoppered conical flask. Accurately add 10 ml of methanol and weigh. Ultrasonicate for 30 minutes, cool, weigh again, replenish the loss in weight with methanol, mix well, filter, and use the subsequent filtrate as the test solution. Procedure Inject accurately 10 μl each of the reference solution and the test solution into the chromatograph, and calculate the content. It contains not less than 0.50% of salidroside (C14H20O7), calculated with reference to the dried drug. Prepared Slices Processing Remove the fibrous roots, eliminate foreign matter, cut into slices, and dry. Description Rounded, subrounded, or irregular slices. Externally brown, reddish-brown, or dark brown, some bearing a layer of yellow membranous epidermis with a cerise decorative pattern after removal of the outer epidermis. Cut surface cerise to purplish-red, sometimes with fissures. Texture light and lax. Odour aromatic; taste initially slightly bitter and astringent, then sweet. Extractives Carry out the method for determination of water-soluble extractives (2201, hot extraction method). It contains not less than 25.0%. Assay Total Anthraquinone Carry out the method for high-performance liquid chromatography (0512). Chromatographic System and System Suitability Use octadecylsilane-bonded silica gel as the stationary phase and a mixture of methanol and 0.1% phosphoric acid (85 : 15) as the mobile phase. Detection wavelength: 254 nm. The number of theoretical plates is not less than 3000, calculated with reference to the peak of emodin. Reference Solution Accurately weigh aloe-emodin CRS, rhein CRS, emodin CRS, chrysophanol CRS, and physcion CRS, respectively. Prepare stock solutions in methanol containing: Aloe-emodin: 80 μg/ml Rhein: 80 μg/ml Emodin: 80 μg/ml Chrysophanol: 80 μg/ml Physcion: 40 μg/ml Accurately measure 2 ml of each stock solution and mix to obtain a reference solution containing: Aloe-emodin: 16 μg/ml Rhein: 16 μg/ml Emodin: 16 μg/ml Chrysophanol: 16 μg/ml Physcion: 8 μg/ml Test Solution Accurately weigh 0.15 g of the powder (through No. 4 sieve) into a stoppered conical flask. Accurately add 25 ml of methanol and weigh. Heat under reflux on a water bath for 1 hour, cool, weigh again, replenish the loss of solvent with methanol, mix well, and filter. Accurately measure 5 ml of the subsequent filtrate into a flask and evaporate to dryness. Add 10 ml of 8% hydrochloric acid, ultrasonicate for 2 minutes, then add 10 ml chloroform. Heat under reflux for 1 hour, cool, and transfer to a separating funnel. Wash the flask with a small quantity of chloroform and combine the washings. Separate the chloroform layer. Extract the aqueous layer with three 10 ml portions of chloroform. Combine the chloroform extracts and evaporate to dryness under reduced pressure. Dissolve the residue in methanol, transfer to a 10 ml volumetric flask, dilute to volume with methanol, and mix well. Procedure Inject accurately 10 μl each of the reference solution and the test solution. Calculate the content. It contains not less than 1.5% of the total amount of aloe-emodin (C15H10O5), rhein (C15H8O6), emodin (C15H10O5), chrysophanol (C15H10O4), and physcion (C16H12O5), calculated with reference to the dried drug. Free Anthraquinone Carry out the method for high-performance liquid chromatography (0512). Chromatographic System and System Suitability As described under Total Anthraquinone. Reference Solution As described under Total Anthraquinone. Test Solution Accurately weigh 0.5 g of the powder (through No. 4 sieve) into a stoppered conical flask. Add accurately 25 ml of methanol and weigh. Heat under reflux on a water bath for 1 hour, cool, weigh again, replenish the loss of solvent with methanol, mix well, filter, and use the subsequent filtrate as the test solution. Procedure Inject accurately 10 μl each of the reference solution and the test solution. Calculate the content. It contains not less than 0.20% of the total amount of aloe-emodin, rhein, emodin, chrysophanol, and physcion, calculated with reference to the dried drug. Assay For the prepared slices: Total Anthraquinone As required for the crude drug. Free Anthraquinone Not less than 0.35%, following the method described for the crude drug.

中文说明

[性味归经]:寒,苦。归脾、胃、大肠、肝、心、三焦、小肠、膀胱经。沉。 用法用量:煎服,3-30克,用于泻下不宜久煎;研末服,1-3克。酒炒,上达巅顶;酒洗,中至胃脘;生用,下行。凡表证未罢,血气虚弱、脾胃虚寒,无实热、积滞、瘀结者,以及妇女怀孕、月经期、哺乳期应慎用或忌用。 [功效主治]:1,泻热,润肠,泻下攻积,用于肠道积滞,大便秘结。2,凉血泻火,用于血热妄行之吐血,衄血,火邪上炎之目赤,咽痛,牙龈肿痛等。3,清热解毒,用于热毒疮疡及烧伤等。4,活血祛瘀通经,用于妇女瘀血闭经,产后恶露不下,症瘕积聚,跌打损伤。 [现代研究]: 本品含有蒽醌类化合物约3%,包括游离状态和结合状态大黄酸、大黄酚、大黄素、芦荟大黄素、大黄素甲醚、蜈蚣苔素,其主要的泻下成分为结合性大黄酸蒽酮-番泻甙A、B、C,其中番泻甙A为主要有效成分。此外,尚含鞣质约5%以及游离没食子酸、桂皮酸及其酯类等。叶含槲皮甙,惟掌叶大黄的叶以金丝桃甙含量最多。 1,掌叶大黄及唐古特大黄泻下的有效成分是结合状态的大黄酸和其类似物。本品因含鞣质及没食子酸等,又具收敛作用,故大剂量使用大黄时先泻后便秘。若煎药时间过长,则蒽醌类化合物及结合性大黄酸和其类似物破坏较多,鞣酸等成分大量煎出,故仅有致便秘作用,而无泻下作用。2,有增加血小板、促进血液凝固等止血作用。3,本品可促进胆汁等消化液分泌,有利胆、排石和增进消化作用。4,保肝作用:有抗中毒性肝炎的作用,使SGPT明显下降。大黄注射液对急性黄疸性肝炎有明显的退黄作用。5,解热作用:大黄能使感染性发热患者和动物体温下降;可使发热家兔第三脑室灌流液内前列腺素E水平下降。6,抗炎作用:大黄煎剂对多种不同炎症模型均有显著的对抗作用,对以渗出和肉芽增生为主的炎症过程均有抑制作用。7,降压作用:大黄酊剂、浸剂经家兔试验有降压作用,其中以酊剂效果较好。8,大黄素对抗乙酰胆碱引起的小鼠离体肠痉挛作用强于对抗豚鼠气管痉挛的作用。9,本品有降低血清高胆固醇的作用。10,掌叶大黄及大黄酸、大黄素均有利尿作用,以大黄酸作用最强。11,大黄在体内可辅助病毒诱生干扰素,增加人体白细胞干扰素诱导效价,提高患者体内干扰素水平。12,大黄对慢性肾功能不全大鼠,可明显降低血中尿素氮及肌酐含量。13,大黄能提高小鼠腹腔巨噬细胞的吞噬功能。14,大黄对大鼠实验性胃溃疡有保护作用。15,大黄水煎液对小